AGIOS PHARMACEUTICALS, INC. Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for March 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 96.33 | 2,426 | 233,697 | 176,966 | 179.4 K to 177 K (-1.35 %) |
| Mar 30 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 96.35 | 2,426 | 233,745 | 176,966 | 179.4 K to 177 K (-1.35 %) |
| Mar 30 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 90.81 | 2,426 | 220,305 | 179,392 | 181.8 K to 179.4 K (-1.33 %) |
| Mar 30 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 90.84 | 2,426 | 220,378 | 179,392 | 181.8 K to 179.4 K (-1.33 %) |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 106.24 | 7,000 | 743,680 | 112,835 | 119.8 K to 112.8 K (-5.84 %) |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 31.64 | 6,068 | 191,992 | 111,269 | |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 23.10 | 3,477 | 80,319 | 117,337 | |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.69 | 455 | 313 | 120,814 | |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 106.24 | 10,000 | 1,062,400 | 0 | 10 K to 0 (-100.00 %) |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 31.64 | 6,068 | 191,992 | 10,000 | 3.9 K to 10 K (+154.32 %) |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 23.10 | 3,477 | 80,319 | 3,932 | 455 to 3.9 K (+764.18 %) |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.69 | 455 | 314 | 455 | 0 to 455 |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 5,500 | 2,571 | 302,817 | |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 106.81 | 5,500 | 587,455 | 42,770 | 48.3 K to 42.8 K (-11.39 %) |
| Mar 18 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 5,500 | 2,571 | 48,270 | 42.8 K to 48.3 K (+12.86 %) |
| Mar 09 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 110.16 | 2,600 | 286,416 | 102,501 | 105.1 K to 102.5 K (-2.47 %) |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | A | 107.89 | 30,600 | 3,301,434 | 121,269 | |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | A | 107.89 | 68,000 | 7,336,520 | 365,022 | |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 107.89 | 17,000 | 1,834,130 | 137,000 | |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 107.89 | 68,000 | 7,336,520 | 308,317 | |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Grant | A | 39.35 | 270 | 10,625 | 42,770 | 42.5 K to 42.8 K (+0.64 %) |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 107.89 | 136,000 | 14,673,040 | 889,320 | |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 25,000 | 7,563 | 753,320 | |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 107.05 | 1,300 | 139,165 | 105,101 | 106.4 K to 105.1 K (-1.22 %) |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 107.05 | 6,500 | 695,825 | 241,772 | 248.3 K to 241.8 K (-2.62 %) |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 25,000 | 7,563 | 248,272 | 223.3 K to 248.3 K (+11.20 %) |